CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Kuros Biosciences AG Company Snapshot
Kuros Biosciences AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kuros Biosciences AG with three other miscellaneous service companies in Europe: Faron Pharmaceuticals Oy of the United Kingdom (2016 sales of £946,543.82 [US$1.23 million] ), Silence Therapeutics Plc of the United Kingdom (£770,000.00 [US$999,999.00 ] ), and Oxford Pharmascience Group PLC which is also based in the United Kingdom (£796,000.00 [US$1.03 million] of which 100% was Delivery systems).

Sales Analysis. Sales fell dramatically in 2016: During the year ended December of 2016, sales at Kuros Biosciences AG were 1.06 million Swiss Francs (US$1.11 million). This is a sharp decrease of 83.3% versus 2015, when the company's sales were 6.36 million Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Kuros Biosciences AG
  Stock Performance Chart for Kuros Biosciences AG
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 12.50
(Figures in Swiss Francs)
1 Week 0.0%   13 Weeks -15.3%  
4 Weeks -28.9%   52 Weeks -51.6%  
 
Kuros Biosciences AG Key Data:
  Ticker: KURN Country: Switzerland
  Exchanges: GVA ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,061,000
(Year Ending Jan 2017).
Employees: 16
  Currency: Swiss Francs Market Cap: 65,012,836
  Fiscal Yr Ends: December Shares Outstanding: 5,201,027
  Share Type: Inhaberaktie Closely Held Shares: 2,850,181
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.